Stockholm, June 22, 2022 - Nasdaq (Nasdaq: NDAQ) announced today the results of
the semi-annual review of the First North 25 Index, (Nasdaq Stockholm: FN25),
which will become effective at market open
HUDDINGE, Sweden, April 19, 2022 /PRNewswire/ Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa
With effect from March 28, 2022, the subscription rights in Karo Pharma AB will
be traded on First North Growth Market. Trading will continue up until and
including April 06, 2022. Instrument: Subscription
Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa, Switzerland, Singapore, the United States or any other jurisdiction in which the distribution or release would be unlawful or require further registration measures.